Jiangsu Hengrui reported CNY6.9B in Current Liabilities for its fiscal quarter ending in September of 2026.





Current Liabilities Change Date
Cspc Pharmaceutical CNY 10.18B 65.36M Dec/2025
Kangmei Pharma CNY 5.1B 280.48M Jun/2026
Sh Fosun Pharma CNY 35.3B 3.29B Sep/2026
Sh Pharmaceutical CNY 140.51B 88.41M Sep/2026
Sino Biopharmaceutical CNY 24.85B 5.29B Jun/2025
Wuxi Apptec CNY 23.85B 4.94B Sep/2026
Zz Pientze Pharmaceu CNY 2.74B 277.02M Sep/2026